Seres Therapeutics, Inc. (MCRB): 424B5 filed Aug 4, 2026

Form type
424B5
Filing date
Aug 4, 2026
Accession number
0001193125-26-332730
Filer
Seres Therapeutics, Inc. (CIK 1609809)